Low-dose tofacitinib with 308-nm excimer therapy successfully induced repigmentation in patients with refractory vitiligo.

Wei-Cheng FangSheng-Yiao LinShu-Mei HuangCheng-Che E Lan

Published in: Clinical and experimental dermatology (2022)

Combining low-dose tofacitinib with 308-nm excimer may be an effective treatment for patients with nonsegmental vitiligo who were refractory to conventional therapies.

Keyphrases

low dose
rheumatoid arthritis
high dose
photodynamic therapy
ulcerative colitis
high glucose
diabetic rats
drug induced
stem cells
oxidative stress
endothelial cells
stress induced